Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    

GALENA BIOPHARMA INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancialsRevisions 
Financials (USD)
Sales 2018 -
EBIT 2018 -20,6 M
Net income 2018 -23,5 M
Debt 2018 -
Yield 2018 -
Sales 2019 -
EBIT 2019 -25,4 M
Net income 2019 -26,9 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 0
Capi. / Sales2019 0
Capitalization 31,1 M
More Financials
Company
Galena Biopharma (NASDAQ: GALE) is publicly traded pharmaceutical company based in Lake Oswego in the U.S. state of Oregon. The 19-employee company was originally started as Argonaut Pharmaceuticals and later became RXi Pharmaceuticals, both based in Worcester, Massachusetts, and is headed by... 
Sector
Pharmaceuticals
Calendar
05/09 | 05:20pmPresentation
More about the company
Latest news on GALENA BIOPHARMA INC
04/20SELLAS LIFE SCIENCES GROUP, INC. : Change in Directors or Principal Officers, Fi..
AQ
04/20SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Of..
GL
04/16SELLAS Life Sciences Reports Corporate Highlights, Advancements for its Cance..
GL
04/16SELLAS LIFE SCIENCES GROUP, INC. : Results of Operations and Financial Condition..
AQ
04/13SELLAS LIFE SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
04/13SELLAS LIFE SCIENCES : Financial Statements and Exhibits (form 8-K/A)
AQ
04/10SELLAS LIFE SCIENCES GROUP, INC. : Other Events (form 8-K)
AQ
04/04SELLAS LIFE SCIENCES : NeuVax + Herceptin combination treatment shows significan..
AQ
04/03SELLAS LIFE SCIENCES : rises on Phase IIb TNBC data
AQ
04/03SELLAS LIFE SCIENCES : Announces Positive Interim Data from Phase 2b NeuVax (nel..
AQ
More news
Sector news : Pharmaceuticals - NEC
08:48aTAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/20$SLS - Galena Biopharma #SLS Given Daily Media Impact Rating of 0.23  
04/13SELLAS Life Sciences Group Inc GALE Pharmaceuticals Healthcare Deals and Alli.. 
02/13 SELLAS Life Sciences Group Inc GALE Medical Equipment Deals and Alliances Pr.. 
01/03Head to Head Comparison: Tetraphase Pharmaceuticals $TTPH & Galena Biopha.. 
2017 ? Galena Biopharma, Inc. Stockholders Approve Business Combination with SELL.. 
More tweets
Qtime:90
News from SeekingAlpha
2016Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 Results - Earnings Cal.. 
2016Galena Biopharma beats by $0.02 
2016Notable earnings after Wednesday?s close 
2016RXI PHARMACEUTICALS : Moving On Promising Scar Treatment 
2016Best And Worst Performing Stocks Of 2016 
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | US3632561086 | 4-Traders
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 12,0 $
Spread / Average Target 123%
EPS Revisions
Managers
NameTitle
Angelos M. Stergiou President, Chief Executive Officer & Director
Jane Wasman Independent Chairman
Aleksey N. Krylov Chief Financial Officer, Treasurer & Director
Nicholas J. Sarlis Director, Chief Medical Officer & Senior VP
Gregory M. Torre Director, Chief Regulatory Officer & Senior VP
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC31
JOHNSON & JOHNSON-8.71%342 627
PFIZER1.13%217 064
NOVARTIS-6.21%213 465
ROCHE HOLDING LTD.-12.17%193 713
MERCK AND COMPANY4.55%158 813